2m 2m 2m 2m 2m 2m 2m
SUTRO BIOPHARMA (STRO)
NASDAQ
$26.05-$1.79 (-6.43%)
Price as of Jul 14, 2026 4:15 PM EDT- $461.3MMarket Cap
- 264.54%1-Year Change
- BiotechnologyIndustry
SUTRO BIOPHARMA (STRO)
$26.05-$1.79 (-6.43%)
STRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.84 | ||
Change | -$1.89 (-6.36%) | ||
Open | $29.51 | ||
High | $29.89 | ||
Low | $27.76 | ||
Previous Close | $29.73 | ||
Volume | 210,748 | ||
30-Day Average Volume | 486,073 | ||
1-Week Change | -9.11% | ||
1-Month Change | -3.33% | ||
1-Year Change | 264.54% | ||
3-Year Change | -41.88% | ||
5-Year Change | -84.43% | ||
Fundamentals | |||
Shares Outstanding | 16.6M | ||
Total Assets | $242.0M | ||
Market Cap | $461.3M | ||
Enterprise Value | $387.6M | ||
Period: QTR TTM FY | |||
Revenue | $14.5M | ||
Net Income | -$38.5M | ||
Free Cash Flow | -$42.3M | ||
EBIT | -$38.5M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $150.2M | ||
EPS | -$2.94 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 27 | ||
P/B | -7 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/03/2025 | ||
Earnings & Revenue